Logo ofThe Capital Market Authority (CMA)
The Capital Market Authority (CMA) announced today, Dec. 31, its board of directors’ approval of Kesay Clinics Co.’s request to register and float 2 million shares on the Nomu-Parallel Market. 
The stake represents 5% of the company’s 40 million share capital, the market regulator said in a statement.
The offer will be confined to qualified investors stipulated in the glossary of defined terms used in the CMA regulations and rules. The prospectus will be published within sufficient time prior to the IPO start.
The CMA confirmed that its approval is valid for six months. It will be deemed void if the share offering and listing are not completed within this period.
Logo ofThe Capital Market Authority (CMA)
The Capital Market Authority (CMA) announced today, Dec. 31, its board of directors’ approval of Kesay Clinics Co.’s request to register and float 2 million shares on the Nomu-Parallel Market.
The stake represents 5% of the company’s 40 million share capital, the market regulator said in a statement.
The offer will be confined to qualified investors stipulated in the glossary of defined terms used in the CMA regulations and rules. The prospectus will be published within sufficient time prior to the IPO start.
The CMA confirmed that its approval is valid for six months. It will be deemed void if the share offering and listing are not completed within this period.
